Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Sameer Nath

Concepts (163)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiosurgery
17
2019
398
2.510
Why?
Prostatic Neoplasms
6
2019
972
1.070
Why?
Brain Neoplasms
9
2018
1325
0.980
Why?
Lung Neoplasms
11
2019
2675
0.860
Why?
Radiotherapy, Intensity-Modulated
7
2019
143
0.790
Why?
Radiation Oncology
3
2021
83
0.770
Why?
Oncology Nursing
1
2021
35
0.630
Why?
Carcinoma, Non-Small-Cell Lung
6
2019
1195
0.610
Why?
Chemoradiotherapy
2
2019
238
0.600
Why?
Radiation Dosage
3
2019
193
0.600
Why?
Organs at Risk
1
2019
37
0.590
Why?
Immunity, Cellular
1
2019
277
0.510
Why?
Brachytherapy
2
2017
132
0.490
Why?
Radiotherapy Dosage
9
2017
289
0.420
Why?
Positron-Emission Tomography
4
2018
343
0.410
Why?
Mycosis Fungoides
1
2014
63
0.400
Why?
Curriculum
1
2021
1079
0.390
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1998
0.360
Why?
Aged, 80 and over
14
2019
8391
0.360
Why?
Kaplan-Meier Estimate
5
2019
970
0.360
Why?
Four-Dimensional Computed Tomography
1
2011
38
0.330
Why?
Aged
23
2019
26432
0.310
Why?
Urogenital System
1
2009
16
0.300
Why?
Particle Accelerators
1
2009
9
0.300
Why?
Radiography, Interventional
1
2011
128
0.300
Why?
Multivariate Analysis
4
2019
1543
0.280
Why?
Proportional Hazards Models
3
2019
1331
0.280
Why?
Radiation Injuries
1
2009
149
0.270
Why?
Neoplasm Recurrence, Local
2
2015
1160
0.270
Why?
Gastrointestinal Tract
1
2009
203
0.250
Why?
Follow-Up Studies
11
2018
5439
0.250
Why?
Middle Aged
18
2019
36619
0.240
Why?
Magnetic Resonance Imaging
7
2018
3926
0.240
Why?
Skin Neoplasms
1
2014
806
0.240
Why?
Radiation Pneumonitis
2
2017
31
0.240
Why?
Glioma
1
2010
425
0.230
Why?
Male
24
2021
73396
0.230
Why?
Small Cell Lung Carcinoma
2
2018
125
0.230
Why?
Radiotherapy
2
2017
209
0.210
Why?
Adult
15
2021
41087
0.210
Why?
Uterine Cervical Neoplasms
3
2013
269
0.200
Why?
Treatment Outcome
10
2019
11821
0.190
Why?
Humans
34
2021
146342
0.190
Why?
Cranial Irradiation
3
2018
85
0.180
Why?
Female
21
2021
79499
0.160
Why?
Radiotherapy, Computer-Assisted
2
2010
12
0.160
Why?
Multimodal Imaging
2
2018
137
0.150
Why?
Survival Analysis
5
2018
1378
0.150
Why?
Education, Nursing
1
2021
92
0.150
Why?
Neoplasm Metastasis
2
2019
693
0.150
Why?
Programmed Cell Death 1 Receptor
2
2018
268
0.150
Why?
Retrospective Studies
11
2019
17438
0.140
Why?
Lymphopenia
1
2019
62
0.140
Why?
Combined Modality Therapy
2
2019
1271
0.140
Why?
Brain
2
2010
2991
0.140
Why?
Leukocyte Count
1
2019
321
0.140
Why?
Tumor Hypoxia
1
2018
7
0.140
Why?
Neutropenia
1
2019
153
0.140
Why?
Needs Assessment
1
2021
404
0.130
Why?
Immune System
1
2019
181
0.130
Why?
CTLA-4 Antigen
1
2018
105
0.130
Why?
Circulating Tumor DNA
1
2018
50
0.130
Why?
Disease-Free Survival
1
2019
778
0.130
Why?
Absorbable Implants
1
2017
38
0.130
Why?
Lymphocytes
1
2019
379
0.130
Why?
Carcinoma, Squamous Cell
2
2013
628
0.120
Why?
Ultrasonography
2
2018
788
0.120
Why?
Disease Progression
3
2019
2867
0.120
Why?
Hydrogel, Polyethylene Glycol Dimethacrylate
1
2017
80
0.120
Why?
Androgen Antagonists
1
2017
91
0.120
Why?
Neoplasm Staging
6
2018
1488
0.120
Why?
Chi-Square Distribution
1
2017
517
0.120
Why?
Antibodies
1
2018
400
0.120
Why?
Chemotherapy, Adjuvant
1
2017
429
0.110
Why?
Prognosis
5
2018
4351
0.110
Why?
Heart
1
2019
626
0.110
Why?
Propensity Score
1
2017
376
0.110
Why?
Time Factors
3
2018
7109
0.110
Why?
Age Factors
2
2014
3347
0.110
Why?
Dose-Response Relationship, Radiation
2
2018
141
0.110
Why?
Odds Ratio
1
2017
1077
0.100
Why?
Tomography, X-Ray Computed
4
2018
2786
0.100
Why?
Treatment Failure
2
2015
361
0.100
Why?
United States
6
2021
16136
0.100
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2015
228
0.100
Why?
Neoadjuvant Therapy
1
2017
475
0.100
Why?
Marital Status
1
2014
47
0.100
Why?
Risk Factors
4
2017
10921
0.100
Why?
Cisplatin
2
2013
347
0.100
Why?
Neutrophils
1
2019
1133
0.100
Why?
Salvage Therapy
2
2015
166
0.100
Why?
SEER Program
1
2014
233
0.090
Why?
Logistic Models
1
2017
2126
0.090
Why?
Young Adult
5
2017
14330
0.090
Why?
Melanoma
1
2018
765
0.080
Why?
Databases, Factual
1
2017
1493
0.080
Why?
Cervix Uteri
1
2011
50
0.080
Why?
Practice Patterns, Physicians'
2
2010
1408
0.080
Why?
Biomarkers, Tumor
1
2018
1339
0.080
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2011
121
0.080
Why?
Cone-Beam Computed Tomography
1
2009
32
0.080
Why?
Prostatectomy
1
2009
93
0.070
Why?
Cause of Death
1
2011
456
0.070
Why?
Radiotherapy, Adjuvant
1
2009
222
0.070
Why?
Survival Rate
4
2016
2092
0.070
Why?
Postoperative Period
1
2009
355
0.070
Why?
Tumor Burden
1
2010
326
0.070
Why?
Registries
1
2017
2400
0.070
Why?
Surveys and Questionnaires
1
2021
6073
0.070
Why?
Image-Guided Biopsy
2
2018
41
0.070
Why?
Sex Factors
1
2014
2107
0.070
Why?
Neurosurgical Procedures
1
2009
209
0.060
Why?
Imaging, Three-Dimensional
1
2011
582
0.060
Why?
Diagnostic Imaging
1
2009
340
0.060
Why?
Neoplasm Grading
2
2018
313
0.060
Why?
Healthcare Disparities
1
2014
733
0.060
Why?
Incidence
1
2014
2936
0.060
Why?
Comorbidity
1
2011
1665
0.060
Why?
Head and Neck Neoplasms
1
2011
563
0.060
Why?
Lung
1
2019
4122
0.060
Why?
Neoplasms
2
2010
2954
0.050
Why?
Severity of Illness Index
1
2009
2921
0.040
Why?
Physicians
1
2009
955
0.040
Why?
Prospective Studies
3
2018
8123
0.040
Why?
Automation
1
2020
104
0.040
Why?
Patient Positioning
1
2020
73
0.040
Why?
Radiotherapy Planning, Computer-Assisted
2
2011
150
0.040
Why?
False Positive Reactions
1
2018
124
0.030
Why?
Statistics, Nonparametric
1
2018
426
0.030
Why?
B7-H1 Antigen
1
2018
245
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
200
0.030
Why?
Radiometry
1
2015
56
0.030
Why?
Child, Preschool
1
2010
11913
0.030
Why?
Risk Assessment
2
2017
3712
0.030
Why?
Radiology
1
2017
175
0.030
Why?
Fibrosis
1
2017
568
0.030
Why?
Diagnosis, Differential
1
2018
1503
0.020
Why?
Sensitivity and Specificity
1
2017
1998
0.020
Why?
Immunotherapy
1
2018
671
0.020
Why?
Adolescent
1
2010
22557
0.020
Why?
Motion
1
2011
94
0.020
Why?
Vinblastine
1
2010
75
0.020
Why?
Child
1
2010
22693
0.020
Why?
Longitudinal Studies
1
2018
3017
0.020
Why?
Radiographic Image Enhancement
1
2010
57
0.020
Why?
Decision Making
1
2017
993
0.020
Why?
Carboplatin
1
2010
168
0.020
Why?
Utilization Review
1
2009
39
0.020
Why?
Confidence Intervals
1
2010
329
0.020
Why?
Tomography Scanners, X-Ray Computed
1
2009
21
0.020
Why?
Algorithms
1
2017
1849
0.020
Why?
Hysterectomy
1
2010
139
0.020
Why?
Fluorouracil
1
2010
231
0.020
Why?
Rectum
1
2010
180
0.020
Why?
Health Care Surveys
1
2010
541
0.020
Why?
Urinary Bladder
1
2010
194
0.020
Why?
Equipment Design
1
2009
520
0.020
Why?
Cohort Studies
1
2018
6077
0.020
Why?
Radiography
1
2009
861
0.020
Why?
Data Collection
1
2009
650
0.020
Why?
Mutation
1
2018
4093
0.020
Why?
Case-Control Studies
1
2013
3647
0.010
Why?
Antineoplastic Agents
1
2010
2219
0.010
Why?
Nath's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)